Role ofMDR1gene polymorphisms in gingival overgrowth induced by cyclosporine in transplant patients
- 2 November 2008
- journal article
- Published by Wiley in Journal of Periodontal Research
- Vol. 43 (6) , 665-672
Abstract
Background and Objective: The aim of the present study was to determine the association between genotypes of theMDR1gene, encoding P‐glycoprotein, and gingival overgrowth in transplant patients treated with cyclosporine, and to evaluate the effect of periodontal treatment in these patients.Material and Methods: Fifty transplant patients receiving therapy with cyclosporine and suffering from gingival overgrowth were subjected to nonsurgical periodontal treatment and received oral hygiene instructions. Hyperplastic index, periodontal probing depths, bleeding and plaque scores were recorded at baseline and after 3 and 6 mo. Patients were dichotomized into two groups: those with a hyperplastic index of < 30% (minimal gingival overgrowth) and those with a hyperplastic index of ≥ 30% (clinically significant gingival overgrowth).MDR1C3435T and G2677T polymorphisms were evaluated in all patients and in 100 controls.Results: At baseline, 32 patients (64%) had minimal gingival overgrowth and 18 patients (36%) had clinically significant gingival overgrowth. The mutated C3435T genotype was significantly more frequent in the second group (p < 0.019). The significant association between gingival overgrowth and the 3435TT genotype was confirmed by logistic regression analysis (p < 0.031). The differences in hyperplastic index, observed at baseline between patients with the TT genotype and those with the CC/CT genotype disappeared in the second and third evaluation. The mean monthly change of the square root of the gingival overgrowth scores for all patients, assessed using linear models, was significantly different from baseline (−0.17 points per month,p < 0.00001); and this was particularly evident in subjects with renal transplant (−1.62,p < 0.01).Conclusion: Aetiological periodontal and self‐performed maintenance therapy is effective in reducing gingival overgrowth, particularly in subjects with the 3435TT genotype and in patients with renal transplant.Keywords
This publication has 38 references indexed in Scilit:
- Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockersJournal of Clinical Periodontology, 2005
- Cyclosporin A‐Induced Gingival Overgrowth in Renal Transplant PatientsJournal of Periodontology, 2003
- The rôle of time in reducing gingival overgrowth in heart‐transplanted patients following cyclosporin therapyJournal of Clinical Periodontology, 2000
- Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapyJournal of Clinical Periodontology, 1998
- Gingival Overgrowth in Cyclosporine A Treated Multiple Sclerosis PatientsJournal of Periodontology, 1994
- Gingival hyperplasia in renal allograft recipients receiving cyclosporin‐A and calcium antagonistsJournal of Clinical Periodontology, 1993
- Drugs and the periodontiumJournal of Clinical Periodontology, 1988
- Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasiaOral Surgery, Oral Medicine, Oral Pathology, 1986
- Severe Gingival Overgrowth Associated with Cyclosporine TherapyJournal of Periodontology, 1986
- Cyclosporine Therapy: Its Significance to the PeriodontistJournal of Periodontology, 1984